Columbia Overseas Core Fund Institutional 3 (COSOX)
11.32
+0.02
(+0.18%)
USD |
May 06 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.84% | 943.01M | 3.20% | 42.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -60.64M | 15.08% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide shareholders with long-term capital appreciation. Under normal circumstances, the Fund invests at least 80% of its net assets in equity securities of foreign companies. The Fund may invest in securities of or relating to issuers believed to be undervalued, represent growth opportunities, or both. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Multi-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Columbia Threadneedle Investments |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
70
-429.31M
Peer Group Low
1.306B
Peer Group High
1 Year
% Rank:
66
-60.64M
-2.358B
Peer Group Low
9.103B
Peer Group High
3 Months
% Rank:
79
-498.76M
Peer Group Low
2.073B
Peer Group High
3 Years
% Rank:
76
-3.073B
Peer Group Low
26.37B
Peer Group High
6 Months
% Rank:
63
-1.184B
Peer Group Low
5.306B
Peer Group High
5 Years
% Rank:
25
-94.89B
Peer Group Low
47.45B
Peer Group High
YTD
% Rank:
68
-983.15M
Peer Group Low
2.588B
Peer Group High
10 Years
% Rank:
29
-47.30B
Peer Group Low
127.00B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 07, 2025.
Asset Allocation
As of March 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.44% |
| Stock | 99.56% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| AstraZeneca PLC | 2.45% | 70.26 | -2.54% |
| Shell PLC | 2.28% | 34.62 | 4.54% |
| Prosus NV | 2.26% | 50.05 | 0.00% |
| Sanofi SA | 2.19% | 106.65 | -1.62% |
| Northern Star Resources Ltd | 2.18% | 12.85 | -3.38% |
| ING Groep NV | 2.05% | 18.54 | 0.00% |
| ASR Nederland NV | 2.03% | 54.90 | 0.00% |
| Check Point Software Technologies Ltd | 1.99% | 220.84 | 0.31% |
| Mitsubishi UFJ Financial Group Inc | 1.90% | 12.10 | -1.63% |
| Sankyo Co Ltd | 1.87% | 13.80 | 0.00% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.75% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 0.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide shareholders with long-term capital appreciation. Under normal circumstances, the Fund invests at least 80% of its net assets in equity securities of foreign companies. The Fund may invest in securities of or relating to issuers believed to be undervalued, represent growth opportunities, or both. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Multi-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Columbia Threadneedle Investments |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-6-25) | 3.84% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 16.81 |
| Weighted Average Price to Sales Ratio | 3.020 |
| Weighted Average Price to Book Ratio | 2.592 |
| Weighted Median ROE | 12.47% |
| Weighted Median ROA | 5.96% |
| ROI (TTM) | 10.42% |
| Return on Investment (TTM) | 10.42% |
| Earning Yield | 0.0750 |
| LT Debt / Shareholders Equity | 0.5589 |
As of March 31, 2025
Growth Metrics
| EPS Growth (1Y) | 20.28% |
| EPS Growth (3Y) | 20.10% |
| EPS Growth (5Y) | 12.60% |
| Sales Growth (1Y) | 8.06% |
| Sales Growth (3Y) | 11.03% |
| Sales Growth (5Y) | 7.73% |
| Sales per Share Growth (1Y) | 12.69% |
| Sales per Share Growth (3Y) | 11.27% |
| Operating Cash Flow - Growth Ratge (3Y) | 16.27% |
As of March 31, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:COSOX", "name") |
| Broad Asset Class: =YCI("M:COSOX", "broad_asset_class") |
| Broad Category: =YCI("M:COSOX", "broad_category_group") |
| Prospectus Objective: =YCI("M:COSOX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |